Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and αvβ3 integrins - Tam, SH; Sassoli, PM; Jordan, RE; Nakada, MT (Circulation, 1998)